Macrophage cytotherapy on liver cirrhosis

Dabing Ping; Yuan Peng; Xudong Hu; Chenghai Liu; Chenghai Liu; Chenghai Liu

doi:10.3389/fphar.2023.1265935

Frontiers in Pharmacology (Dec 2023)

Macrophage cytotherapy on liver cirrhosis

Dabing Ping,
Yuan Peng,
Xudong Hu,
Chenghai Liu,
Chenghai Liu,
Chenghai Liu

Affiliations

Dabing Ping: Institute of Liver Diseases, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, Shanghai, China
Yuan Peng: Institute of Liver Diseases, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, Shanghai, China
Xudong Hu: Department of Biology, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Chenghai Liu: Institute of Liver Diseases, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, Shanghai, China
Chenghai Liu: Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, China
Chenghai Liu: Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai, China

DOI: https://doi.org/10.3389/fphar.2023.1265935
Journal volume & issue: Vol. 14

Abstract

Read online

Macrophages, an essential cell population involved in mediating innate immunity in the host, play a crucial role on the development of hepatic cirrhosis. Extensive studies have highlighted the potential therapeutic benefits of macrophage therapy in treating hepatic cirrhosis. This review aims to provide a comprehensive overview of the various effects and underlying mechanisms associated with macrophage therapy in the context of hepatic cirrhosis.

Published in Frontiers in Pharmacology

ISSN: 1663-9812 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: http://journal.frontiersin.org/journals/pharmacology

About the journal

Abstract

Keywords